A visual summary of the EUROCARE-4 results: a UK perspective.
BACKGROUND
This paper provides a one-page visual summary of the previously published relative survival estimates for 42 types of cancers in 23 countries in Europe.


METHODS
The cancer patients in these analyses were 15 years or older at the time of their diagnosis in the period 1995-1999. Follow-up was to the end of 2003 and relative survival estimates were computed by the cohort method.


RESULTS
The analysis of 1-year survival had good discriminatory power and visibly separated a group of countries with consistently high survival estimates (Switzerland, France, Sweden, Belgium and Italy) and another group of countries with lower estimates (Poland, Czech Republic, Ireland, Denmark and United Kingdom-Northern Ireland). After the first year, there was less variation between the countries.


CONCLUSIONS
To more fully understand the UK situation, a rational comparison would select countries with data-quality, prosperity and healthcare systems that are similar to the United Kingdom. In otherwise comparable populations, a pronounced difference in 1-year survival is most likely to be due to variation in a strong prognostic factor, which exerts its effect in the short term. A likely explanation for the short-term survival deficit in the United Kingdom compared with the Nordic countries is a less favourable stage distribution in the United Kingdom. However, the present superficial analysis does not exclude possible functions for other factors relating to the organisation and quality of cancer care services.
Møller
H
H
Thames Cancer Registry, Kings College London, 42 Weston Street, London, UK. henrik.moller@kcl.ac.uk
Linklater
K M
KM
Robinson
D
D
D005060:Europe / Q000453:epidemiology; D006801:Humans; D009369:Neoplasms / Q000401:mortality*; D006113:United Kingdom / Q000453:epidemiology